Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

73.68 -0.45 (-0.61%)
Streaming Delayed Price Updated: 3:15 PM EDT, Jun 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 282,881
Open 75.00
Bid (Size) 73.56 (2)
Ask (Size) 73.79 (1)
Prev. Close 74.13
Today's Range 73.66 - 76.20
52wk Range 19.54 - 117.75
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GeneDx to Participate in Upcoming Investor Conferences
From GeneDx
Via Business Wire
GeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at Scale
From GeneDx
Via Business Wire

Performance

YTD
-7.5%
-7.5%
1 Month
-34.5%
-34.5%
3 Month
-22.4%
-22.4%
6 Month
-8.4%
-8.4%
1 Year
+258.9%
+258.9%

More News

Read More
Analyst Expectations For GeneDx Holdings's Future
Via Benzinga
This National Vision Holdings Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday
Via Benzinga
Earnings Scheduled For April 30, 2025
Via Benzinga
GeneDx Announces Completion of Fabric Genomics Acquisition
From GeneDx
Via Business Wire
Why Investors Were Avoiding GeneDx Holdings Stock This Week
Via The Motley Fool
Retail Buzz Swirls Around GeneDx As Shares Sink 43% Despite Earnings Beat
Via Stocktwits
Wednesday's session: top gainers and losers
Via Chartmill
Top stock movements in today's session.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Wednesday's session: gap up and gap down stocks
Via Chartmill
Why GeneDx Holdings Stock Is Plunging Today
Via The Motley Fool
Crude Oil Falls Over 3%; Regulus Therapeutics Shares Spike Higher
Via Benzinga
Exposures Fossil Fuels
These stocks that are showing activity before the opening bell on Wednesday.
Via Chartmill
S&P 500 Falls 2%; Caterpillar Reports Downbeat Q1 Results
Via Benzinga
Topics Stocks
Exposures US Equities
IBD 50 Stock GeneDx Hammered Despite Earnings Beat-And-Raise
Via Investor's Business Daily
Topics Government
Exposures Political
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
GeneDx Reports First Quarter 2025 Financial Results and Business Highlights
From GeneDx
Via Business Wire
Exploring high growth characteristics of GENEDX HOLDINGS CORP (NASDAQ:WGS).
Via Chartmill
GeneDx Eyes Global Genomic Leadership With Fabric Genomics Buyout For Up To $51 Million
Via Benzinga
IBD 50's GeneDx Inks $84 Million AI-Tied Takeover Deal
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale
From GeneDx
Via Business Wire
Why GENEDX HOLDINGS CORP (NASDAQ:WGS) could fit Mark Minervini’s high-growth criteria
Via Chartmill
GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025
From GeneDx
Via Business Wire

Frequently Asked Questions

Is GeneDx Holdings Corp. - Class A Common Stock publicly traded?
Yes, GeneDx Holdings Corp. - Class A Common Stock is publicly traded.
What exchange does GeneDx Holdings Corp. - Class A Common Stock trade on?
GeneDx Holdings Corp. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GeneDx Holdings Corp. - Class A Common Stock?
The ticker symbol for GeneDx Holdings Corp. - Class A Common Stock is WGS on the Nasdaq Stock Market
What is the current price of GeneDx Holdings Corp. - Class A Common Stock?
The current price of GeneDx Holdings Corp. - Class A Common Stock is 73.68
When was GeneDx Holdings Corp. - Class A Common Stock last traded?
The last trade of GeneDx Holdings Corp. - Class A Common Stock was at 06/03/25 03:15 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.